The rapid growth of freestanding emergency departments in Texas has been accompanied by an equal increase in use at relatively high prices that lead to sizable out-of-pocket costs to patients, according to new research by ...
Mar 23, 2017
0
0
Researchers from the Indian Institute of Management Calcutta, University of Chicago, and Management Development Institute, Gurgaon have published a new study that examines the unintended consequences of an Indian government ...
Jun 4, 2024
0
0
In a new study from the University of Bergen (UiB), confidential drug prices have been used to evaluate coverage decisions for new drugs in Norway.
Jun 29, 2022
0
4
Tobacco use imposes a significant health and economic burden on countries. Research estimates that the cost of smoking in South Africa amounted to 0.97% of the country's GDP in 2016. These costs are likely to have increased ...
Dec 6, 2022
0
8
China's top economic planner is to investigate 60 pharmaceutical companies for excessive charges, including several joint ventures with foreign firms, state media reported Thursday.
Jul 4, 2013
0
0
Swiss pharmaceutical group Roche said Monday it is sticking by its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina and is extending it for a month.
Feb 27, 2012
0
0
Supersized alcopops are ready-to-drink flavored alcoholic beverages with high alcohol content. Drinking just one of the 23.5 oz. cans constitutes binge drinking. Drinking multiple cans can lead to alcohol poisoning and death. ...
Jun 12, 2019
0
1
China reported a rise in new virus cases Monday, possibly denting optimism that disease control measures including isolating major cities might be working, while the operator of a cruise ship in Japan reported dozens of new ...
Feb 10, 2020
0
2
After weeks of criticism from patients, doctors and other drugmakers for hiking a life-saving medicine's price more than fifty-fold, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.
Nov 25, 2015
0
2
New research findings presented at the 2019 ACR/ARP Annual Meeting found that annual spending on biologic DMARDS (biologics) by U.S. public programs and beneficiaries nearly doubled from 2012 to 2016. The study showed post-market ...
Nov 10, 2019
0
1
